Supplementary Figure S1 from EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Proapoptotic Regulators

2026 Open access

Read full text
Authors: Naiara Perurena, Marina Watanabe, Amy E. Schade, William Brown, Elizabeth Y. Luo, Alycia Gardner, Alexandra Indeglia, Akiko Yoshinaga, Rhea Sahu, Yoona Yang, Simon Knott, Karen M. Cichowski
DOI: 10.1158/0008-5472.31744784
Cited by: 0

Abstract

The combination of EZH2 and HER2 family kinase inhibitors is effective in HER2+ breast cancer cells

Fields of Study & Subjects

HER2/EGFR in Cancer Research Epigenetics and DNA Methylation Histone Deacetylase Inhibitors Research

Publication details

Publication date
16 March 2026
Language
EN